• Company
• Ultomiris is reimbursed for aHUS in Korea
• by Son, Hyung Min Jan 16, 2025 06:14am

• Company
• Last year's pharma export sales recorded KRW 11T
• by Kim, Jin-Gu Jan 16, 2025 06:14am

• Company
• Elahere receives orphan drug designation in Korea
• by Eo, Yun-Ho Jan 16, 2025 06:13am

• Company
• Companies develop new drugs for Fabry disease
• by Son, Hyung Min Jan 16, 2025 06:13am

• Company
• JW Pharma's hemophilia assay for patients using 'Hemlibra'
• by Kim, Jin-Gu Jan 16, 2025 06:13am

• Company
• China-made new drugs actively enter the global market
• by Son, Hyung Min Jan 16, 2025 06:13am

• Company
• ‘Global healthcare M&A to recover this year... AI-China’
• by Cha, Jihyun Jan 15, 2025 05:53am

• Company
• Cholangiocarcinoma·AML targeted anticancer drug 'Tibsovo'
• by Eo, Yun-Ho Jan 15, 2025 05:53am

• Company
• Samsung Biologics signs largest CMO deal…KRW 2 Trillion
• by Cha, Jihyun Jan 15, 2025 05:52am

• Company
• Hanmi leads the prescription market for 7 consecutive years
• by Chon, Seung-Hyun Jan 15, 2025 05:52am